News Theranos unveils new technologies, but concerns linger Desktop testing device and cloud-based diagnostic platform announced.
News Programmable lab-on-chip advancing in trials A digital device the size of a credit card could provide a diagnosis in just minutes for a huge range of conditions.
News J&J jumps on the MFN pricing train Johnson & Johnson is the latest pharma group to agree a Most-Favoured Nation (MFN) drug pricing deal with the Trump administration to avert tariffs.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
